Home >> Healthcare >> Food & Beverage >>

Clinical Trial Imaging (Software And Services) By Technology (Echo, PET, MRI, X Ray, CT, Ultrasound And Other) Market For Biotech Companies, Pharmaceuticals, Research Center, Hospitals, And Other End-Users: Global Industry Perspective, Comprehensive Analysis, Size, Share, Growth, Segment, Trends and Forecast, 2015 - 2021

Published: May-2016 | Format: PDF | Zion | Number of pages: 130 | Code: MRS - 59874

The report covers forecast and analysis for the clinical trial imaging market on a global and regional level. The study provides historic data of 2015 along with a forecast from 2016 to 2021 based revenue (USD million). The study includes drivers and restraints for the market along with the impact they have on the demand over the forecast period. Additionally, the report includes study of opportunities available in the clinical trial imaging market on a global level.

In order to give the users of this report a comprehensive view on the clinical trial imaging market, we have included a detailed competitive scenario, and product portfolio of key vendors. To understand the competitive landscape in the market, an analysis of Porter’s five forces model for the clinical trial imaging market has also been included. The study encompasses a market attractiveness analysis, wherein product segments are benchmarked based on their market size, growth rate and general attractiveness.

The study provides a decisive view on the clinical trial imaging market by segmenting the market based on product, technology, end user and region. Software and service are segments of product, where, Software is designed for clinical trial imaging. Services including operational imaging services, reader service, system and technology, design consulting. Various technologies in clinical imaging include echo, PET, MRI, x ray, CT, and ultrasound among others. MRI, CT, X-ray, ultrasound are the technologies having highest share in clinical trial imaging market. Different end users in this market are biotech companies, pharmaceuticals, research center, hospitals, diagnosis centers and others. All the segments have been analyzed based on present and future trends and the market is estimated from 2015 to 2021. The regional segmentation includes the current and forecast demand for North America, Europe, Asia Pacific, Latin America and Middle East and Africa with its further bifurcation into major countries including U.S. Germany, France, UK, China, Japan, India and Brazil.

The report covers detailed competitive outlook including company profiles of the key participants operating in the global market. The key players of clinical trials imaging market include Cardiovascular Imaging Technologies, VirtualScopic, Biomedical Systems, BioClinica, Intrinsic Imaging LLC, Prism Clinical Imaging, PAREXEL International Corporation, and ICON among others.

This report segments the global clinical trial imaging market as follows:

Clinical Trials Imaging Market: Product Segment Analysis

  • Service
  • Software

Clinical Trials Imaging Market: Technology Segment Analysis

  • X-ray
  • CT
  • MRI
  • PET
  • Echo
  • Ultrasound
  • Other technologies

Clinical Trials Imaging Market: End user Segment Analysis

  • Biotech companies
  • Pharmaceutical
  • Research centers
  • Hospitals
  • Other end users

Clinical trial imaging Market: Regional Segment Analysis

  • North America
    • US
  • Europe
    • Germany
    • France
    • UK
  • Asia Pacific
    • China
    • Japan
    • India
  • Latin America
    • Brazil
  • Middle East and Africa
  • Chapter 1. Preface
    • 1.1. Report description
    • 1.2. Research scope
    • 1.3. Research methodology
    • 1.4. Market research process
    • 1.5. Market research methodology
  • Chapter 2. Executive Summary
    • 2.1. Global clinical trial imaging market, 2015 - 2021 (USD Million)
    • 2.2. Global clinical trial imaging market : Snapshot
  • Chapter 3. Clinical Trial Imaging – Industry Analysis
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Drivers for global clinical trial imaging market: Impact analysis
        • 3.2.1.1. Rising geriatric population and growing occurrences of chronic diseases
        • 3.2.1.2. Growth in pharmaceutical & biotechnology industries
    • 3.3. Market Restraints
      • 3.3.1. Restraints for Global Clinical Trial Imaging Market: Impact Analysis
        • 3.3.1.1. High cost of machinery
    • 3.4. Opportunities
      • 3.4.1. Porter’s Five Forces Analysis
    • 3.5. Clinical Trial Imaging : Market Attractiveness Analysis
      • 3.5.1. Market Attractiveness Analysis by Product Segment
      • 3.5.2. Market Attractiveness Analysis by Technology Segment
      • 3.5.3. Market Attractiveness Analysis by End-User Segment
      • 3.5.4. Market Attractiveness Analysis by Regional Segment
  • Chapter 4. Clinical Trail Imaging Market – Competitive Landscape
    • 4.1. Company Market Share Analysis, 2014
    • 4.2. Patent Analysis (2001 – 2016)
      • 4.2.1. Number of Patents (2001 – 2016)
      • 4.2.2. Patent Share, by Geography
      • 4.2.3. Patent Share by Company
      • 4.2.4. U.S. (U.S. Patent)
      • 4.2.5. Europe (EP Documents)
      • 4.2.6. Japan (Abstract of Japan)
      • 4.2.7. Global (WIPO (PCT))
  • Chapter 5. Clinical Trial Imaging Market – Product Segment Analysis
    • 5.1.1. Global clinical trial imaging market overview: by product
      • 5.1.1.1. Global clinical trial imaging market revenue share, by product, 2015 & 2021
    • 5.2. Service
      • 5.2.1. Global clinical trial imaging market for service, 2015 – 2021 (USD Million)
    • 5.3. Software
      • 5.3.1. Global clinical trial imaging market for software, 2015 – 2021 (USD Million)
  • Chapter 6. Clinical Trial Imaging Market – Technology Segment Analysis
    • 6.1. Global clinical trial imaging market overview: by technology
      • 6.1.1. Global clinical trial imaging market revenue share, by technology, 2015 & 2021
    • 6.2. X-ray
      • 6.2.1. Global clinical trial imaging market for X-ray, 2015 – 2021 (USD Million)
    • 6.3. CT
      • 6.3.1. Global clinical trial imaging market for CT, 2015 – 2021 (USD Million)
    • 6.4. MRI
      • 6.4.1. Global clinical trial imaging market for MRI, 2015 – 2021 (USD Million)
    • 6.5. PET
      • 6.5.1. Global clinical trial imaging market for PET, 2015 – 2021 (USD Million)
    • 6.6. Echo
      • 6.6.1. Global clinical trial imaging market for echo, 2015 – 2021 (USD Million)
    • 6.7. Ultrasound
      • 6.7.1. Global clinical trial imaging market for ultrasound, 2015 – 2021 (USD Million)
    • 6.8. Others
      • 6.8.1. Global clinical trial imaging market for others, 2015 – 2021 (USD Million)
  • Chapter 7. Clinical Trial Imaging Market – End User Segment Analysis
    • 7.1. Global clinical trial imaging market overview: by end user
      • 7.1.1. Global clinical trial imaging market revenue share, by end user, 2015 & 2021
    • 7.2. Biotech Companies
      • 7.2.1. Global clinical trial imaging market for biotech companies, 2015 – 2021 (USD Million)
    • 7.3. Pharmaceutical
      • 7.3.1. Global clinical trial imaging market for pharmaceutical, 2015 – 2021 (USD Million)
    • 7.4. Research Centers
      • 7.4.1. Global clinical trial imaging market for research centers, 2015 – 2021 (USD Million)
    • 7.5. Hospitals
      • 7.5.1. Global clinical trial imaging market for hospitals, 2015 – 2021 (USD Million)
    • 7.6. Others
      • 7.6.1. Global clinical trial imaging market for other end-uses, 2015 – 2021 (USD Million)
  • Chapter 8. Clinical Trial Imaging Market – Regional Analysis
    • 8.1. Global Clinical Trial Imaging Market : Regional Overview
      • 8.1.1. Global clinical trial imaging market revenue share, by region, 2015 & 2021
    • 8.2. North America
      • 8.2.1. North America clinical trial imaging market, 2015 - 2021 (USD Million)
    • 8.3. North America clinical trial imaging market revenue by product, 2014 - 2020 (USD Million)
      • 8.3.1. North America clinical trial imaging market revenue, by technology, 2015 – 2021 (USD Million)
    • 8.4. North America clinical trial imaging market revenue, by end-user, 2015 – 2021 (USD Million)
    • 8.5. U.S.
      • 8.5.1. U.S. clinical trial imaging market revenue, by product, 2015 – 2021 (USD Million)
      • 8.5.2. U.S. clinical trial imaging market revenue, by technology, 2015 – 2021 (USD Million)
      • 8.5.3. U.S. clinical trial imaging market revenue, by end-user, 2015 – 2021 (USD Million)
    • 8.6. Europe
      • 8.6.1. Europe clinical trial imaging market, 2015 - 2021 (USD Million)
      • 8.6.2. Europe clinical trial imaging market revenue by product, 2014 - 2020 (USD Million)
      • 8.6.3. Europe clinical trial imaging market revenue, by technology, 2015 – 2021 (USD Million)
      • 8.6.4. Europe clinical trial imaging market revenue, by end-user, 2015 – 2021 (USD Million)
    • 8.7. UK
      • 8.7.1. UK clinical trial imaging market revenue, by product, 2015 – 2021 (USD Million)
      • 8.7.2. UK clinical trial imaging market revenue, by technology, 2015 – 2021 (USD Million)
      • 8.7.3. UK clinical trial imaging market revenue, by end-user, 2015 – 2021 (USD Million)
    • 8.8. France
      • 8.8.1. France clinical trial imaging market revenue, by product, 2015 – 2021 (USD Million)
      • 8.8.2. France clinical trial imaging market revenue, by technology, 2015 – 2021 (USD Million)
      • 8.8.3. France clinical trial imaging market revenue, by end-user, 2015 – 2021 (USD Million)
      • 8.8.4. Germany
        • 8.8.4.1. Germany clinical trial imaging market revenue, by product, 2015 – 2021 (USD Million)
        • 8.8.4.2. Germany clinical trial imaging market revenue, by technology, 2015 – 2021 (USD Million)
        • 8.8.4.3. Germany clinical trial imaging market revenue, by end-user, 2015 – 2021 (USD Million)
    • 8.9. Asia Pacific
      • 8.9.1. Asia Pacific clinical trial imaging market, 2015 - 2021 (USD Million)
      • 8.9.2. Asia Pacific clinical trial imaging market revenue by product, 2014 - 2020 (USD Million)
      • 8.9.3. Asia Pacific clinical trial imaging market revenue, by technology, 2015 – 2021 (USD Million)
      • 8.9.4. Asia Pacific clinical trial imaging market revenue, by end-user, 2015 – 2021 (USD Million)
      • 8.9.5. China
        • 8.9.5.1. China clinical trial imaging market revenue, by product, 2015 – 2021 (USD Million)
        • 8.9.5.2. China clinical trial imaging market revenue, by technology, 2015 – 2021 (USD Million)
        • 8.9.5.3. China clinical trial imaging market revenue, by end-user, 2015 – 2021 (USD Million)
      • 8.9.6. Japan
        • 8.9.6.1. Japan clinical trial imaging market revenue, by product, 2015 – 2021 (USD Million)
        • 8.9.6.2. Japan clinical trial imaging market revenue, by technology, 2015 – 2021 (USD Million)
        •  
        • 8.9.6.3. Japan clinical trial imaging market revenue, by end-user, 2015 – 2021 (USD Million)
      • 8.9.7. India
        • 8.9.7.1. India clinical trial imaging market revenue, by product, 2015 – 2021 (USD Million)
        • 8.9.7.2. India clinical trial imaging market revenue, by technology, 2015 – 2021 (USD Million)
        • 8.9.7.3. India clinical trial imaging market revenue, by end-user, 2015 – 2021 (USD Million)
    • 8.10. Latin America
      • 8.10.1. Latin America clinical trial imaging market, 2015 - 2021 (USD Million)
      • 8.10.2. Latin America clinical trial imaging market revenue by product, 2014 - 2020 (USD Million)
      • 8.10.3. Latin America clinical trial imaging market revenue, by technology, 2015 – 2021 (USD Million)
      • 8.10.4. Latin America clinical trial imaging market revenue, by end-user, 2015 – 2021 (USD Million)
      • 8.10.5. Brazil
        • 8.10.5.1. Brazil clinical trial imaging market revenue, by product, 2015 – 2021 (USD Million)
        • 8.10.5.2. Brazil clinical trial imaging market revenue, by technology, 2015 – 2021 (USD Million)
        • 8.10.5.3. Brazil clinical trial imaging market revenue, by end-user, 2015 – 2021 (USD Million)
    • 8.11. Middle East & Africa
      • 8.11.1. Middle East & Africa clinical trial imaging market, 2015 - 2021 (USD Million)
      • 8.11.2. Middle East & Africa clinical trial imaging market revenue by product, 2014 - 2020 (USD Million)
      • 8.11.3. Middle East & Africa clinical trial imaging market revenue, by technology, 2015 – 2021 (USD Million)
      • 8.11.4. Middle East & Africa clinical trial imaging market revenue, by end-user, 2015 – 2021 (USD Million)
  • Chapter 9. Company Profile
    • 9.1. ICON plc
      • 9.1.1. Overview
      • 9.1.2. Financials
      • 9.1.3. Product Portfolio
      • 9.1.4. Business strategies
      • 9.1.5. Recent Developments
    • 9.2. PAREXEL International Corporation
      • 9.2.1. Overview
      • 9.2.2. Financials
      • 9.2.3. Product Portfolio
      • 9.2.4. Business Strategy
      • 9.2.5. Recent developments
    • 9.3. Cardiovascular Imaging Technologies, LLC.
      • 9.3.1. Company overview
      • 9.3.2. Financial
      • 9.3.3. Product portfolio
      • 9.3.4. Business strategy
    • 9.4. Biomedical Systems
      • 9.4.1. Overview
      • 9.4.2. Financials
      • 9.4.3. Product portfolio
      • 9.4.4. Business strategies
      • 9.4.5. Recent Developments
    • 9.5. BioClinica
      • 9.5.1. Overview
      • 9.5.2. Financials
      • 9.5.3. Product portfolio
      • 9.5.4. Business strategies
      • 9.5.5. Recent Developments
    • 9.6. Prism Clinical Imaging
      • 9.6.1. Overview
      • 9.6.2. Financials
      • 9.6.3. Product portfolio
      • 9.6.4. Business strategies
    • 9.7. VirtualScopics
      • 9.7.1. Overview
      • 9.7.2. Product portfolio
      • 9.7.3. Business strategies
      • 9.7.4. Recent Developments
    • 9.8. Intrinsic Imaging LLC
      • 9.8.1. Overview
      • 9.8.2. Financials
      • 9.8.3. Product portfolio

List of Tables

1. Global clinical trial imaging market : Snapshot
2. Drivers for global clinical trial imaging market: Impact analysis
3. Restraints For Global Clinical Trial Imaging Market: Impact Analysis
4. North America clinical trial imaging market revenue by product, 2014 - 2020 (USD Million)
5. North America clinical trial imaging market revenue, by technology, 2015 – 2021 (USD Million)
6. North America clinical trial imaging market revenue, by end-user, 2015 – 2021 (USD Million)
7. U.S. Clinical trial imaging market revenue, by product, 2015 – 2021 (USD Million)
8. U.S. clinical trial imaging market revenue, by technology, 2015 – 2021 (USD Million)
9. U.S. clinical trial imaging market revenue, by end-user, 2015 – 2021 (USD Million)
10. Europe clinical trial imaging market revenue by product, 2014 - 2020 (USD Million)
11. Europe clinical trial imaging market revenue, by technology, 2015 – 2021 (USD Million)
12. Europe clinical trial imaging market revenue, by end-user, 2015 – 2021 (USD Million)
13. UK clinical trial imaging market revenue, by product, 2015 – 2021 (USD Million)
14. UK clinical trial imaging market revenue, by technology, 2015 – 2021 (USD Million)
15. UK clinical trial imaging market revenue, by end-user, 2015 – 2021 (USD Million)
16. France clinical trial imaging market revenue, by product, 2015 – 2021 (USD Million)
17. France clinical trial imaging market revenue, by technology, 2015 – 2021 (USD Million)
18. France clinical trial imaging market revenue, by end-user, 2015 – 2021 (USD Million)
19. Germany clinical trial imaging market revenue, by product, 2015 – 2021 (USD Million)
20. Germany clinical trial imaging market revenue, by technology, 2015 – 2021 (USD Million)
21. Germany clinical trial imaging market revenue, by end-user, 2015 – 2021 (USD Million)
22. Asia Pacific clinical trial imaging market revenue by product, 2014 - 2020 (USD Million)
23. Asia Pacific clinical trial imaging market revenue, by technology, 2015 – 2021 (USD Million)
24. Asia Pacific clinical trial imaging market revenue, by end-user, 2015 – 2021 (USD Million)
25. China clinical trial imaging market revenue, by product, 2015 – 2021 (USD Million)
26. China clinical trial imaging market revenue, by technology, 2015 – 2021 (USD Million)
27. China clinical trial imaging market revenue, by end-user, 2015 – 2021 (USD Million)
28. Japan clinical trial imaging market revenue, by product, 2015 – 2021 (USD Million)
29. Japan clinical trial imaging market revenue, by technology, 2015 – 2021 (USD Million)
30. Japan clinical trial imaging market revenue, by end-user, 2015 – 2021 (USD Million)
31. India clinical trial imaging market revenue, by product, 2015 – 2021 (USD Million)
32. India clinical trial imaging market revenue, by technology, 2015 – 2021 (USD Million)
33. India clinical trial imaging market revenue, by end-user, 2015 – 2021 (USD Million)
34. Latin America clinical trial imaging market revenue by product, 2014 - 2020 (USD Million)
35. Latin America clinical trial imaging market revenue, by technology, 2015 – 2021 (USD Million)
36. Latin America clinical trial imaging market revenue, by end-user, 2015 – 2021 (USD Million)
37. Brazil clinical trial imaging market revenue, by product, 2015 – 2021 (USD Million)
38. Brazil clinical trial imaging market revenue, by technology, 2015 – 2021 (USD Million)
39. Brazil clinical trial imaging market revenue, by end-user, 2015 – 2021 (USD Million)
40. Middle East & Africa clinical trial imaging market revenue by product, 2014 - 2020 (USD Million)
41. Middle East & Africa clinical trial imaging market revenue, by technology, 2015 – 2021 (USD Million)
42. Middle East & Africa clinical trial imaging market revenue, by end-user, 2015 – 2021 (USD Million)


List of Figures

1. Market Research Process
2. Market Research Methodology
3. Global clinical trial imaging market, 2015 - 2021 (USD Million)
4. Percentage Distribution of Population Aged 65 and Over by Region: 2015 and 2050
5. Porter’s Five Forces Analysis
6. Market Attractiveness Analysis by Product Segment
7. Market Attractiveness Analysis by Technology Segment
8. Market Attractiveness Analysis by End-User Segment
9. Market Attractiveness Analysis by Regional Segment
10. Company Market Share Analysis, 2014
11. Global clinical trial imaging market revenue share, by product, 2015 & 2021
12. Global clinical trial imaging market for service, 2015 – 2021 (USD Million)
13. Global clinical trial imaging market for software, 2015 – 2021 (USD Million)
14. Global clinical trial imaging market revenue share, by technology, 2015 & 2021
15. Global clinical trial imaging market for X-ray, 2015 – 2021 (USD Million)
16. Global clinical trial imaging market for CT, 2015 – 2021 (USD Million)
17. Global clinical trial imaging market for MRI, 2015 – 2021 (USD Million)
18. Global clinical trial imaging market for PET, 2015 – 2021 (USD Million)
19. Global clinical trial imaging market for echo, 2015 – 2021 (USD Million)
20. Global clinical trial imaging market for ultrasound, 2015 – 2021 (USD Million)
21. Global clinical trial imaging market for others, 2015 – 2021 (USD Million)
22. Global clinical trial imaging market revenue share, by end user, 2015 & 2021
23. Global clinical trial imaging market for biotech companies, 2015 – 2021 (USD Million)
24. Global clinical trial imaging market for pharmaceutical, 2015 – 2021 (USD Million)
25. Global clinical trial imaging market for research centers, 2015 – 2021 (USD Million)
26. Global clinical trial imaging market for hospitals, 2015 – 2021 (USD Million)
27. Global clinical trial imaging market for other end-uses, 2015 – 2021 (USD Million)
28. Global clinical trial imaging market revenue share, by region, 2015 & 2021
29. North America clinical trial imaging market, 2015 - 2021 (USD Million)
30. Europe clinical trial imaging market, 2015 - 2021 (USD Million)
31. Asia Pacific clinical trial imaging market, 2015 - 2021 (USD Million)
32. Latin America clinical trial imaging market, 2015 - 2021 (USD Million)
33. Middle East & Africa clinical trial imaging market, 2015 - 2021 (USD Million)

Inquiry For Buying

Please fill your details below, to inquire about this report:
Indicates required fields

Request Sample

Please fill your details below, to receive sample report:
Indicates required fields


Zion Research uses the synergy of combination of both primary research and secondary research for its research reports. For this study, we have conducted extensive primary research, wherein we have conducted in-depth interviews of the key opinion leader of this industry. Primary research make up for the biggest chunk of our data sources in addition to secondary research.

We referred to product literature of leading industry participants, annual reports, press releases, government publications, and other relevant sources for data collection and analysis thereof. Secondary research also includes a search of recent trade journals, technical writing, internet sources, and statistical data from government websites, trade associations and agencies.

Zion Research has collected key data related to the Clinical trial imaging Market and analyzed these data using a variety of methods. The market dynamics have been ascertained following a detailed study of the micro, meso, and macroeconomic indicators of the market.

This report is based on in-depth qualitative and quantitative analyses of the Global  Clinical trial imaging Market. The quantitative analysis involved the application of various projection and sampling techniques. The qualitative analysis involved primary interviews, surveys, and vendor briefings. The data gathered as a result of these processes were validated through experts' opinions.

Primary Research

We conduct primary interviews with industry participants and commentators on an ongoing basis to validate data and analysis. A typical research interview fulfills the following functions:

  • Provides firsthand information on market size, market trends, growth trends, competitive landscape, outlook, etc.
  • Helps in validating and strengthening the secondary research findings
  • Further develops the analysis team’s expertise and market understanding
  • Primary research involves e-mail interactions, telephonic interviews as well as face-to-face interviews for each market, category, segment and sub-segment across geographies

Participants who typically partake in such a process include, but are not limited to:

  • Industry participants: CEOs, VPs, marketing/product managers, market intelligence managers and national sales managers
  • Purchasing managers, technical personnel, distributors and resellers
  • Outside experts: Investment bankers, valuation experts and research analysts specializing in specific markets

Key opinion leaders specializing in different areas corresponding to different industry verticals

Secondary Research

Secondary research sources that are typically referred to include, but are not limited to:

  • Company websites, annual reports, financial reports, broker reports, investor presentations and SEC filings
  • IDC and other relevant magazines
  • Internal and external proprietary databases, and relevant patent and regulatory databases
  • National government documents, statistical databases and market reports

News articles, press releases and webcasts specific to companies operating in the market

Based on the research results and technical insights thus gathered, Zion research analysts have provided a comprehensive analysis of the varied aspects of the market. The impact of global economic conditions and other macroeconomic indicators was also considered when assessing the market.

Models

Where no hard data is available, we use models and estimates to produce comprehensive data sets. A rigorous methodology is adopted, wherein the available hard data is cross-referenced with the following data types to produce estimates:

  • Demographic data: Population split by segments
  • Macroeconomic indicators: GDP, PPP, Per Capita Income, etc.
  • Industry indicators: Expenditure, technology stage and infrastructure, sector growth and facilities
  • Data is then cross-checked by an expert panel.

Clinical trial imaging is a technique and process of creating visual representations of the interior of a body for clinical analysis and medical intervention. Clinical trial imaging seeks to reveal internal structures hidden by the skin and bones, as well as to diagnose and treat disease. Imaging clinical trial is a research study conducted with people who volunteer to take part. Clinical trial imaging is part of biological imaging and incorporates radiology which uses the imaging technologies of X-ray radiography, magnetic resonance imaging, medical ultrasonography or ultrasound and others.

Global clinical imaging market is primarily driven by rising geriatric population and growing occurrences of chronic diseases across the globe. Another major driver is growing pharmaceutical & biotechnology industries worldwide. However, high cost related with the machinery and its implementation is a major restraint that may limit the growth of the market. Nonetheless, advancement in technology is likely to disclose the new avenues for clinical trial imaging market in the near future.

Global clinical trial imaging market

Service and software is the key product of the global clinical trial imaging market. Service segment dominated the global clinical trial market in 2015. It accounted for 64.9% share of the total revenue generated in the same year. This trend is predicted to continue within the forecast period.  On the basis of technology, the global clinical trial imaging market is segmented as echo, PET, MRI, X-Ray, CT, and ultrasound and others. CT has the largest share in the clinical trial imaging market and it accounted around 31% share of the total market in 2015. MRI, PET and ultrasound are the important outlets that are expected to grow at above average rate within the forecast period owing to the improvement of the regulatory framework in the emerging markets..

Biotech companies, pharmaceutical, research centers, hospitals and others are the key end-users of the global clinical trial imaging market. Pharmaceutical was one of the foremost end-user industries in clinical trial imaging market in 2015. Biotech companies segment is likely to have a significant growth within the forecast period due to the development in bio-pharmaceutical industries.

North America is expected to have the largest share in the global clinical trials imaging market in 2015. It accounted for over 45% share of the entire market for clinical trial imaging in 2015. North America was followed by Europe. In addition, Asia Pacific is expected to register the fastest growth in terms of demand owing to the emerging economies such as China and India over the years to come.

Some of the key players of the global clinical trial imaging market include Cardiovascular Imaging Technologies, Virtual Scopic, Biomedical Systems, BioClinica, Intrinsic Imaging LLC, Prism Clinical Imaging, PAREXEL International Corporation, and ICON among others.

Single User | $(USD)4199 View Pricing